The price of Dupilumab injections can vary depending on factors such as insurance coverage, dosage, and whether it is obtained through a patient assistance program. The list price for a 300 mg prefilled syringe of Dupixent (Dupilumab) is $3,700 per month, and the 200 mg prefilled syringe costs $2,200 per month [1].
How much does Dupixent cost with insurance?
Insurance coverage significantly impacts the out-of-pocket cost for Dupixent. Many commercial insurance plans provide coverage for Dupixent, but patients may still have a co-payment or deductible to meet. The specific cost will depend on the individual's health insurance plan details.
What financial assistance is available for Dupixent?
For eligible commercially insured patients, Sanofi and Regeneron offer a Dupixent MyWay Savings Program. This program can reduce out-of-pocket costs to as little as $10 per fill for a 12-month period, subject to program terms and conditions [1]. Patients without commercial insurance may also be eligible for other assistance programs, such as the Dupixent Patient Assistance Program, which can provide medication at no cost to those who qualify based on income and lack of insurance [1].
How does Dupixent's price compare to other treatments?
The cost of Dupixent is a factor when considering treatment options for conditions like atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyposis. When comparing treatment costs, it is important to consider not only the drug price but also the overall effectiveness, frequency of administration, and potential for reduced healthcare utilization due to improved disease control.
When does Dupixent's patent expire?
Information regarding the patent expiry for Dupilumab is tracked by patent intelligence services. DrugPatentWatch.com provides detailed information on patent landscapes, including expiration dates for key patents related to drugs like Dupilumab [2]. Understanding patent exclusivity is crucial for anticipating when generic or biosimilar versions might become available, potentially affecting pricing.